Cancer Patient Education

Information for patients with cancer. To be used with Altai Oncology Software and Oncology App

Cancer patient education

Darbepoetin alfa helps your body make more red blood cells. In cancer care, you may get it for anemia caused by chemotherapy to reduce transfusions. It carries risks, including hig

Daratumumab (Darzalex) is an IV monoclonal antibody for multiple myeloma. It can cause infusion reactions and lower blood counts, raising infection and bleeding risks. It may react

Dactinomycin (actinomycin D) is an IV chemotherapy used for certain sarcomas, Wilms tumor, and gestational trophoblastic disease. Key risks include low blood counts, serious liver

Dacomitinib (brand name Vizimpro) is a targeted therapy for certain EGFR-positive non-small cell lung cancers. It blocks growth signals in cancer cells. Key risks include severe di

Dacarbazine is a chemotherapy drug used for melanoma and Hodgkin lymphoma. It can cause low blood counts, serious infections or bleeding, and rare but severe liver problems. It may

Dabrafenib (Tafinlar) is a targeted therapy for cancers with a BRAF V600 mutation. It is often used with trametinib. Key risks include fever, bleeding, eye and heart problems, high